Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
Acta Paediatrica (Oslo, Norway : 1992)|January 12, 2019
Manipulation of oral medication for children by parents and nurses occurs frequently and is often not supported by instructionsAnna C van der Vossen, Linda Al-Hassany, Sandra Buljac, et al.Journal of Hypertension|October 21, 2006
Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal functionAnton H van den Meiracker, Rini Ga Baggen, Sacha Pauli, et al.British Journal of Clinical Pharmacology|June 16, 2009
Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort studyHeleen van der Sijs, Ravi Kowlesar, A Peter J Klootwijk, et al.Pharmaceuticals (Basel, Switzerland)|October 24, 2020
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in GermanyEvelien Moorkens, Teresa Barcina Lacosta, Arnold G Vulto, et al.Patient Preference and Adherence|April 26, 2016
Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in childrenErwin C Vasbinder, Svetlana V Belitser, Patrick C Souverein, et al.The Journal of Pharmacy and Pharmacology|November 2, 2005
Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long-term biological activityElisabeth J Ruijgrok, Marcel H A Fens, Irma A J M Bakker-Woudenberg, et al.Journal of Hypertension|November 5, 2005
Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patientsLidwien M Hanff, Arnold G Vulto, Pieter A Bartels, et al.Antimicrobial Agents and Chemotherapy|April 28, 2006
Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosisElisabeth J Ruijgrok, Marcel H A M Fens, Irma A J M Bakker-Woudenberg, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 3, 2006
Insufficient efficacy of intravenous ketanserin in severe early-onset pre-eclampsiaLidwien M Hanff, Willy Visser, Danielle W E Roofthooft, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 3, 2020
Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature reviewAli M Alsamil, Thijs J Giezen, Toine C Egberts, et al.Pageof 12